Based: Mountain View, CA
Investors: Angels' Forum & the Halo Fund, DFJ InCube Ventures, L Capital Partners, Oxford Bioscience Partners.
Scoop: According to its website, IntraPace is developing a novel implantable system to treat obesity. The abiliti system is designed to be implanted with standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.
IntraPace is one of InCube Labs Chairman Mir Imran's companies. Abiliti has been tested in Germany and last month went on the market in Europe. He hopes to begin U.S. studies this year to bring abiliti to U.S. patients. According to the San Antonio Express, the company was in incubation from 2001 to 2006. Its early-stage investors included Microsoft co-founder Paul Allen, Guidant and Johnson & Johnson Development. Boston Scientific and J&J are in the best position to acquire IntraPace eventually, President and CEO Chuck Brynelsen said recently.